Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $93.6300 (-2.3%) ($93.6300 - $97.1100) on Tue. May. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 35 | Latest Price | $93.6300(-2.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -5.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(56%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.705% in a week (0% probabilities). VIXM(-23%) UUP(-19%) VXX(-16%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $83.32(-11.01%) | Resistance Level | $101.36 | 5 Day Moving Average | $93.59(0.04%) | 10 Day Moving Average | $95.75(-2.21%) | 20 Day Moving Average | $101.36(-7.63%) | To recent high | -25.2% | To recent low | 1.2% | Market Cap | $1.505b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |